✦ LIBER ✦

Fenofibric Acid in Combination with Rosuvastatin 5, 10, or 20 Mg Improves the Atherogenic Lipid Profile in Patients ≥65 Years with Mixed Dyslipidemia

✍ Scribed by Carl J. Pepine; Terry A. Jacobson; Dawn M. Carlson; Maureen T. Kelly; Alex Gold; Michael Cressman; James C. Stolzenbach; Laura A. Williams

Book ID: 119287714
Publisher: Elsevier
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 3
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2009.04.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvements in Lipid Ratios with the Co

Improvements in Lipid Ratios with the Combination of Rosuvastatin 5 mg and Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia

✍ Robert S. Rosenson; Maureen T. Kelly; Carolyn M. Setze; Alex Gold; Michael Cress 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 45 KB

LONG-TERM EFFICACY OF FENOFIBRIC ACID 13

LONG-TERM EFFICACY OF FENOFIBRIC ACID 135 MG IN COMBINATION WITH ROSUVASTATIN 20 MG IN PATIENTS WITH MIXED DYSLIPIDEMIA

✍ Peter H. Jones; Terry A. Jacobson; Carolyn M. Setze; Darryl J. Sleep; Maureen T. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Simultaneous Achievement of Optimal Lipi

Simultaneous Achievement of Optimal Lipid Targets with the Combination of Rosuvastatin 5 mg + Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia

✍ Robert S. Rosenson; Maureen T. Kelly; Carolyn M. Setze; Alex Gold; Michael Cress 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 55 KB

Simultaneous Achievement of Optimal Lipi

Simultaneous Achievement of Optimal Lipid Levels with the Combination of Fenofibric Acid and Rosuvastatin in Patients with Mixed Dyslipidemia

✍ Michael H. Davidson; Peter H. Jones; Aditya Lele; Dawn M. Carlson; Carolyn M. Se 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 52 KB

Combination Rosuvastatin Plus Fenofibric

Combination Rosuvastatin Plus Fenofibric Acid in a Cohort of Patients 65 Years or Older With Mixed Dyslipidemia: Subanalysis of Two Randomized, Controlled Studies

✍ Carl J. Pepine; Terry A. Jacobson; Dawn M. Carlson; Maureen T. Kelly; Carolyn M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

The Efficacy and Safety of 12-Week Treat

The Efficacy and Safety of 12-Week Treatment with Fenofibric Acid Co-Administered with Statins in Patients 65 Years or Older with Mixed Dyslipidemia

✍ Peter H. Jones; Mark S. Kipnes; Maria L. Rios; Carolyn M. Setze; Maureen T. Kell 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 48 KB